GSK Gets FDA Approval for New Lung-Cancer Drug

Regulatory Approvals — GSK Gets FDA Approval for New Lung-Cancer Drug  WSJ

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. November 18, 2026.

By